Skip to search formSkip to main contentSkip to account menu

(124)I-cMAb U36

Known as: 124I-cMAb U36 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Monoclonal AntibodiescMAb U36

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Retrospective cohort study on the safety and efficacy of panitumumab for patients with metastatic colorectal cancer: The HGCSG1002 study—Analysis of after cetuximab refractory.
541 Background: In the previous studies, panitumumab (Pmab) has been demonstrated the efficacy for patients with metastatic… 
2011
2011
[Colorectal cancer chemotherapy and anti-EGFR therapy].
Anti-EGFR antibodies show benefits for some K-ras wild-type patients. Addinganti -VEGF monoclonal antibodies to stateof- the-art… 
2011
2011
Analysis of response rate (RR), liver resection (LR), and toxicity (T) in 129 advanced colorectal cancer (CRC) patients (pts) treated with chronomodulated infusion of ironotecan (I), 5-fluorouracil…
e14099 Background: Advanced CRC pts received chrono-IFLO in three sequential studies: (A) EORTC 05011: 54 pts (Garufi et ASCO… 
Review
1994
Review
1994
Progress in radioimmunotherapy of head and neck-cancer (review).
There is an urgent need for an effective adjuvant systemic therapy for the treatment of patients with advanced head and neck… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)